Similar articles for PMID: 15774430

Year	Number of Results
1970	1
1996	3
1997	2
1998	3
1999	1
2001	3
2002	5
2003	3
2004	4
2005	11
2006	8
2007	3
2008	3
2009	8
2010	4
2011	7
2012	9
2013	1
2014	5
2015	5
2016	7
2017	5
2018	2
2019	5
2020	5
2021	4
2022	2
2024	0

1

Depression in multiple sclerosis: a review.

Siegert RJ, Abernethy DA. Siegert RJ, et al. J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):469-75. doi: 10.1136/jnnp.2004.054635. J Neurol Neurosurg Psychiatry. 2005. PMID: 15774430 Free PMC article. Review.

2

[Cognitive disturbances and attempts of their correction in multiple sclerosis].

Shmidt TE. Shmidt TE. Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(9):54-6. Zh Nevrol Psikhiatr Im S S Korsakova. 2005. PMID: 16252387 Russian. No abstract available.

3

Treatment of cognitive impairment in multiple sclerosis.

Pierson SH, Griffith N. Pierson SH, et al. Behav Neurol. 2006;17(1):53-67. doi: 10.1155/2006/545860. Behav Neurol. 2006. PMID: 16720960 Free PMC article. Review.

4

The relationship of cognitive impairment with neurological and psychiatric variables in multiple sclerosis patients.

Karadayi H, Arisoy O, Altunrende B, Boztas MH, Sercan M. Karadayi H, et al. Int J Psychiatry Clin Pract. 2014 Jan;18(1):45-51. doi: 10.3109/13651501.2013.845221. Epub 2014 Jan 24. Int J Psychiatry Clin Pract. 2014. PMID: 24047424

5

[Depression in multiple sclerosis].

Lebrun C, Cohen M. Lebrun C, et al. Rev Neurol (Paris). 2009 Mar;165 Suppl 4:S156-62. doi: 10.1016/S0035-3787(09)72128-9. Rev Neurol (Paris). 2009. PMID: 19361681 Review. French.

6

Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.

Bagert B, Camplair P, Bourdette D. Bagert B, et al. CNS Drugs. 2002;16(7):445-55. doi: 10.2165/00023210-200216070-00002. CNS Drugs. 2002. PMID: 12056920 Review.

7

[Neuropsychiatric disorders in multiple sclerosis].

García-Moreno JM, Duque P, Izquierdo G. García-Moreno JM, et al. Rev Neurol. 2001 Sep 16-30;33(6):560-7. Rev Neurol. 2001. PMID: 11727241 Free article. Review. Spanish.

8

Psychopharmacology of multiple sclerosis.

Patten SB. Patten SB. Handb Clin Neurol. 2019;165:309-315. doi: 10.1016/B978-0-444-64012-3.00018-6. Handb Clin Neurol. 2019. PMID: 31727219 Review.

9

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.

Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G; COGIMUS Study Group. Patti F, et al. Mult Scler. 2009 Jul;15(7):779-88. doi: 10.1177/1352458509105544. Mult Scler. 2009. PMID: 19542262

10

Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.

Schippling S, O'Connor P, Knappertz V, Pohl C, Bogumil T, Suarez G, Cook S, Filippi M, Hartung HP, Comi G, Jeffery DR, Kappos L, Goodin DS, Arnason B. Schippling S, et al. J Neurol. 2016 Jul;263(7):1418-26. doi: 10.1007/s00415-016-8146-8. Epub 2016 May 13. J Neurol. 2016. PMID: 27177997 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year